Tepnel and SoftGenetics to Offer Rapid Analytics of Congenital Disorders

Tepnel Life Sciences PLC and SoftGenetics today announced an agreement to market and distribute SoftGenetics GeneMarker^® genotyping software for use with Tepnel's Elucigene QST*R products for prenatal detection of common chromosome abnormalities. Elucigene QST*R kits are a range of rapid DNA diagnostic tests that use STR markers to detect the three most common viable autosomal trisomies: trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).

The combination of SoftGenetics GeneMarker software with QST*R will considerably streamline the data analysis process and results reporting time for users of the Elucigene diagnostic test kits.

Elucigene QST*R tests cover a range of DNA-based multiplexed diagnostic assays that use short tandem repeat (STR) markers to detect the three most common viable autosomal trisomies: Down syndrome, Edwards syndrome and Patau syndrome. Additional markers on the sex chromosomes X and Y can detect the most common sex chromosome aneuploidies, Klinefelter syndrome and Turner syndrome. Developed in collaboration with Guy's and St Thomas' Hospital, London, Elucigene QST*R is a rapid testing technique that provides definitive results within 4 hours, including DNA extraction.

SoftGenetics specializes in the development of genetic analysis tools for both research and diagnostic applications.

Full support and documentation for the use of SoftGenetics GeneMarker, with Elucigene QST*R are available for users on the Tepnel website.